Post-traumatic stress disorder in women: current concepts and treatments.
In the US, 13% of women develop post-traumatic stress disorder (PTSD) during their lifetime. An accurate diagnosis of PTSD requires screening for trauma and symptoms of PTSD. Current research in the neurobiologic and psychologic responses to traumatic stress supports the use of pharmacologic and psychosocial interventions. Selective serotonin reuptake inhibitors are the current first-line pharmacotherapy. Efficacious psychosocial interventions include exposure therapy and cognitive processing therapy.
Butterfield
Marian I
MI
Department of Psychiatry, Duke University and the Department of Veterans Affairs Medical Center, 508 Fulton Street, Durham, NC 27705, USA. mimi@acpub.duke.edu
Becker
Mary
M
Marx
Christine E
CE
D001921:Brain / Q000503:physiopathology; D002395:Catecholamines / Q000502:physiology; D015928:Cognitive Behavioral Therapy; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000503:physiopathology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013313:Stress Disorders, Post-Traumatic / Q000503:physiopathology / Q000523:psychology* / Q000628:therapy*
D002395:Catecholamines; D011619:Psychotropic Drugs